SEC Tracker
Get the app

Stem STEM

Stem Q2 FY24: revenue $34.0M; diluted EPS −$71.80

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Stem reported for Q2 FY24, the quarter ended Jun 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$34.0MNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Diluted EPS−$71.80No year-earlier figure tagged. Split-adjusted, as the tables show it; the filing reported −$3.5910-Q income statement, on EDGAR
  3. Cash and cash equivalents$89.6MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  4. Cash from operations−$11.9MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Stem files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (7373) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. CSLM Acquisition CSLMF
  2. Healthcare Triangle HCTI public float $41M, Jun 30, 2025
  3. Veea VEEA public float $40M, Jun 30, 2025
  4. Future Vision II Acquisition FVN public float $61M, Dec 31, 2025
  5. Odysight.ai ODYS public float $35M, Jun 30, 2025